Virulence resistance genes, and transformation amongst environmental isolates of Escherichia coli and Acinetobacter spp.

Journal of Microbiology and Biotechnology

Volumn 22, Issue 1, 2012, Pages 25-33

  Doughari, Hamuel James ^a   Ndakidemi, Patrick Alois ^a   Human, Izanne Susan ^a   Benade, Spinney ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Cell surface hydrophobicity; Extended spectrum beta lactamases; Gelatinases; Hemolysins; Resistance genes; Transformation; Virulence factors

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZTREONAM; BACTERIAL DNA; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GELATINASE; GENTAMICIN; HEMOLYSIN; IMIPENEM; NALIDIXIC ACID; OFLOXACIN; TETRACYCLINE; VEROTOXIN;

ACINETOBACTER; ACINETOBACTER HAEMOLYTICUS; ANTIBIOTIC RESISTANT GENE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; DNA CONTENT; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE TRANSFER; HYDROPHOBICITY; MULTIRESISTANT GENE; NONHUMAN; PLASMID; RESISTANCE GENE;

ACINETOBACTER; ACINETOBACTER HAEMOLYTICUS; ESCHERICHIA COLI;

ACINETOBACTER; BACTERIAL TOXINS; BETA-LACTAMASES; BLOOD BACTERICIDAL ACTIVITY; CELL WALL; DRUG RESISTANCE, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; ESCHERICHIA COLI; GENE TRANSFER, HORIZONTAL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PLASMIDS; TRANSFORMATION, BACTERIAL; VIRULENCE FACTORS;

EID: 84930477358     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1107.07029     Document Type: Article

References (31)

1. Bakar, A. F., A. S. Abdulamir, T. S. Yoke, and N. Nordin. 2010. Detection and quantification of probiotic bacteria using optimized DNA extraction, traditional and real-time PCR methods in complex microbial communities. Afr. J. Biotechnol. 9: 1481-1492.
2. Bolton, D. J. 2011. Verocytotoxigenic (Shiga toxin-producing) Escherichia coli: Virulence factors and pathogenicity in the farm to fork paradigm. Foodborne Pathog. Dis. 8: 357-365.
3. Cross, A. S., K. S. Kim, C. D. Wright, J. C. Sadoff, and P. Gemski. 1986. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J. Infect. Dis. 154: 497-503.
4. Davis, L. G., M. D. Dibner, and J. F. Battery. 1986. In: Basic Methods in Molecular Biology, pp. 135-150. Elsevier Science Publishing Co. Inc., New York.
5. CDC. 2011. Investigation update: Outbreak of Shiga toxinproducing E. coli O104 (STEC O104:H4) infections associated with travel to Germany. Available at http://www.cdc.gov/ecoli/2011/ecoliO104/index.html. Accessed on 2nd July, 2011.
6. Emödy, L., M. Kerényi, and G. Nagy. 2003. Virulence factors of uropathogenic Escherichia coli. Int. J. Antimicrob. Agents 22: 29-33.
7. Grotiuz, G., A. Sirok, P. Gadea, G. Varela, and F. Schelotto. 2006. Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea. J. Clin. Microbiol. 44: 3838-3841.
8. Guardabassi, L., A. Dalsgaard, and J. E. Olsen. 1999. Phenotypic characterization and antibiotic resistance of Acinetobacter spp. isolated from aquatic sources. J. Appl. Microbiol. 87: 659-667.
9. Health Protection Agency. 2007. Identification of Shigella species. National Standard Method BSOP ID 20 Issue 2. Available at http://www.hpa-standardmethods.org.uk/pdf_sops.asp. Accessed 7th June 2011.
10. Iroha, I. R., A. E. O. Ji, and C. O. Esimone. 2008. Antimicrobial resistance pattern of plasmid-mediated extended-spectrum β-lactamase producing strains of Escherichia coli. Sci. Res. Essay 3: 215-218.
11. Jones, R. N., W. A. Craigc, P. G. Ambrose, M. N. Dudley, and S. Pottumarthy. 2005. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 hlactams: Adjustments of breakpoints for strains producing extended spectrum β-lactamases. Diag. Microbiol. Infect. Dis. 52: 235-246.
12. Konig, B., W. Konig, J. Scheffer, J. Hacker, and W. Goebel. 1986. Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: Requirement for release of inflammatory mediators from granulocytes and mast cells. Infect. Immun. 54: 886-892.
13. NARMS. 2004. The US National Antimicrobial Resistance Monitoring System Reports. http://www.ars.usda.gov/Main/docs.htm?docid:6750. Accessed 17th November 2009.
14. National Committee for Clinical Laboratory Standards. 2005. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; 15th Ed. Approved standard (M100-S15). NCCLS, Wayne, PA.
15. National Nosocomial Infections Surveillance (NNIS) System Report. 2000. Data summary from January 1992-April 2000. Am. J. Infect. Control 28: 429-448.
16. Obire, O., D. C. Tamuno, and S. A. Wemedo. 2005. Bacteriological water quality of Elechi Creek in Port Harcourt, Nigeria. J. Appl. Sci. Environ. Mangt. 9: 79-84.
17. Park, S. Y., K. M. Kim, J. H. Lee, S. J. Seo, and I. H. Lee. 2007. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun. 75: 1861-1869.
18. Perilla, G., G. M. S. Agello, C. M. S. Bopp, J. Elliot, R. Facklam, J. S. Knapp, et al. 2003. Manual for laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world, pp. 103-139. WHO.
19. Podar, M., C. B. Abulencia, M. Walcher, D. Hutchison, K. Zengler, J. A. Garcia, et al. 2007. Targeted access to the genomes of low-abundance organisms in complex microbial communities. Appl. Environ. Microbiol. 73: 3205-3214.
20. Raksha, R., H. Srinivasa, and R. S. Macaden. 2003. Occurrence and characterization of Escherichia coli in urinary tract infections. Indian J. Med. Microbiol. 21: 102-107.
21. Ramteke, P. W. and S. Tewari. 2007. Serogroups of Escherichia coli from drinking water. Environ. Monit. Assesst 130: 215-220.
22. Ranjan, K. P., N. Ranjan, A. Chakraborty, and D. R. Arora. 2010. An approach to uropathogenic Escherichia coli in urinary tract infections. J. Lab. Phys. 2: 70-73.
23. Roy, M. R., B. Anne-Marie, T. Marija, R. B. Vicki, R. Jacinta, O. Frances, et al. 2004. Escherichia coli and communityacquired gastroenteritis, Melbourne, Australia. Emerg. Infect. Dis. 10: 1797-1805.
24. Russo, T. A., N. R. Luke, J. M. Beanan, R. Olson, S. L. Sauberan, U. C. MacDonald, et al. 2010. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 78: 3993-4000.
25. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37: 750-753.
26. Sharma, S., G. K. Bhat, and S. Shenoy. 2007. Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections. Indian J. Med. Microbiol. 25: 369-373.
27. Shukla, I., R. Tiwari, and M. Agarwal. 2004. Prevalence of extended spectrum β-lactamase in a tertiary care hospital. Indian J. Med. Microbiol. 22: 87-91.
28. Tarawneh, K. A., N. M. Al-Tawarah, A. H. Abdel-Ghani, A. Al-Majali, M. Ahmed, and K. M. Khleifat. 2009. Characterization of verotoxigenic Escherichia coli (VTEC) isolates from faeces of small ruminants and environmental samples in Southern Jordan. J. Basic Microbiol. 49: 310-317.
29. Thurlow, L. R., V. C. Thomas, S. Narayanan, S. Olson, S. D. Fleming, and L. E. Hancock. 2010. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect. Immun. 78: 4936-4943.
30. WHO. 2002. Water for Health enshrined as a human right. Available at http://www.who.int/mediacentre/news/releases/prl/en. Accessed 1st September 2010.
31. Wilson, J. W., M. J. Schurr, C. L. LeBlanc, R. Ramamurthy, K. L. Buchanan, and C. A. Nickerson. 2002. Mechanisms of bacterial pathogenicity. Postgrad. Med. J. 78: 216-224.